Stay updated on Tralokinumab Efficacy in Asthma Clinical Trial
Sign up to get notified when there's something new on the Tralokinumab Efficacy in Asthma Clinical Trial page.

Latest updates to the Tralokinumab Efficacy in Asthma Clinical Trial page
- Check3 days agoChange DetectedThe page now presents the completed Phase 3 STRATOS2 trial record evaluating tralokinumab for uncontrolled asthma, with detailed study outcomes, participant criteria, and trial locations. It also includes investigator information, publications, and study documents.SummaryDifference100%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe ClinicalTrials.gov page footer now identifies the site revision as v3.8.0 instead of v3.7.2.SummaryDifference0.2%

- Check24 days agoChange DetectedAn NIH announcement banner was added about a website transition and the use of “Super Intelligence” in place of “Artificial Intelligence” across NIH content.SummaryDifference1%

- Check31 days agoChange DetectedThe site footer’s revision label changed from v3.7.1 to v3.7.2 while the page continued to display a 403 error.SummaryDifference0.2%

- Check38 days agoChange DetectedThe site revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check52 days agoChange DetectedThe page now renders a 403 Forbidden error with the site header and a Home link, indicating access is blocked and no study details are currently visible.SummaryDifference16%

Stay in the know with updates to Tralokinumab Efficacy in Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tralokinumab Efficacy in Asthma Clinical Trial page.